Radnor Capital Management, LLC Abbott Laboratories Transaction History

Radnor Capital Management, LLC

$673 Million
Q3 2024

A detailed history of Radnor Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Radnor Capital Management, LLC holds 19,581 shares of ABT stock, worth $2.25 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

19,581

Previous 19,531 0.26%

Holding current value

$2.25 Million

Previous $2.03 Million 10.0%

% of portfolio

0.33%

Previous 0.62%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$100.07 - $118.13 $5,003 - $5,906	50 Added 0.26%	19,581 $2.23 Million
Q2 2024 Jul 12, 2024	BUY	$100.73 - $112.44 $99,823 - $111,428	991 Added 5.35%	19,531 $2.03 Million
Q1 2024 Apr 11, 2024	SELL	$109.52 - $120.96 $192,317 - $212,405	-1,756 Reduced 8.65%	18,540 $2.11 Million
Q4 2023 Jan 11, 2024	BUY	$90.19 - $110.4 $69,716 - $85,339	773 Added 3.96%	20,296 $2.23 Million
Q3 2023 Oct 12, 2023	BUY	$95.53 - $114.62 $1.87 Million - $2.24 Million	19,523 New	19,523 $1.89 Million
Q1 2023 Apr 06, 2023	BUY	$96.86 - $114.01 $183,065 - $215,478	1,890 Added 11.47%	18,361 $1.86 Million
Q3 2022 Oct 12, 2022	BUY	$96.76 - $112.03 $31,543 - $36,521	326 Added 2.02%	16,471 $1.59 Million
Q2 2022 Jul 11, 2022	BUY	$102.07 - $123.37 $111,256 - $134,473	1,090 Added 7.24%	16,145 $1.75 Million
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $343,998 - $419,483	3,017 Added 25.06%	15,055 $1.78 Million
Q4 2021 Jan 20, 2022	BUY	$115.53 - $141.46 $1.39 Million - $1.7 Million	12,038 New	12,038 $1.69 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $921,147 - $1.02 Million	-7,896 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $118,125 - $128,722	1,125 Added 16.61%	7,896 $865,000
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $299,204 - $363,361	3,265 Added 93.13%	6,771 $737,000
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $33,767 - $43,218	441 Added 14.39%	3,506 $321,000
Q3 2019 Oct 07, 2019	SELL	$81.84 - $88.74 $18,414 - $19,966	-225 Reduced 6.84%	3,065 $256,000
Q2 2019 Jul 18, 2019	BUY	$72.88 - $85.0 $239,775 - $279,650	3,290 New	3,290 $277,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Account

Radnor Capital Management, LLC Abbott Laboratories Transaction History